Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

Infect Control Hosp Epidemiol. 1997 Apr;18(4):275-91. doi: 10.1086/647610.


Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacteria / pathogenicity
  • Bacterial Physiological Phenomena
  • Cross Infection / physiopathology
  • Cross Infection / prevention & control*
  • Cross Infection / transmission
  • Drug Resistance, Microbial* / genetics
  • Humans
  • Infection Control / standards*
  • Models, Organizational
  • Organizational Policy*
  • Patient Isolation / standards
  • Societies, Medical / standards*
  • United States


  • Anti-Bacterial Agents